Carisma Therapeutics
Philadelphia, US · Founded 2017 · Delaware corporation · 8 known investors
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
Founders & leadership
SK
Steven KellyinPresident and Chief Executive Officer2018–2025
Board
MC
Margarita ChavezBoard director
EN
Eran NadavBoard director
AS
Althea StillmanBoard director
JG
Jacob GunterbergBoard director
RH
Regina HoditsBoard director
Investors · 8
Reported raises · per SEC filings
Form D private placements$95M disclosed across 3 rounds · 2017–2020
▶$38.3MraisedJan 2021 · 13 investors · BiotechnologyRule 506(b)
▶$38.3MraisedJan 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Briggs MorrisonDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Michael HeffernanDirector
- Chidozie UgwumbaDirector
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Offering amount
- $70.4M
- Amount sold
- $38.3M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$52.9MraisedJul 2020 · 11 investors · BiotechnologyRule 506(b)
▶$52.9MraisedJul 2020 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven KellyExecutive Officer, Director
- Margarita ChavezDirector
- Eran NadavDirector
- Althea StillmanDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Offering amount
- $52.9M
- Amount sold
- $52.9M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.9MraisedApr 2018 · 7 investors · BiotechnologyRule 506(b)
▶$3.9MraisedApr 2018 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Bruce PeacockDirector
- Michael PoiselDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Carisma Therapeutics went on to found or lead other companies.
Competitors · 3
by search overlapSimply Wall St9 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Robinhood9 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwits8 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies competing with Carisma Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Carisma Therapeutics do?
- CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
- Who are Carisma Therapeutics's investors?
- Carisma Therapeutics's investors include Aju IB Invesment Corporation, Anzu Partners, Grazia Equity GmbH, HealthCap, MRL Ventures Fund, Solasta Ventures, Agent Capital, SymBiosis.
- How much funding has Carisma Therapeutics raised?
- Carisma Therapeutics has disclosed $95M raised across 3 rounds.
- Where is Carisma Therapeutics headquartered?
- Carisma Therapeutics is headquartered in Philadelphia, US.